Pulmonary Disease Doctors in South Miami, FL Accepting Medicare

7 Pulmonary Disease doctors found. Showing 1 - 7

Veronica Palmero, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-662-8400

Dr. Ilan Allan Feingold, M.D. Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6200 Sunset Dr, Suite 304, South Miami, FL 33143 Phone: 305-662-1550    Fax: 305-662-5930

Dr. Jenny Stay Machuca, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7000 Sw 62nd Ave, Suite 201, South Miami, FL 33143 Phone: 305-661-9404

Alejandro D Chediak, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7029 Sw 61st Ave, South Miami, FL 33143 Phone: 305-666-2224    Fax: 305-666-2297

Erick Abdiel Palma, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 7000 Sw 62nd Ave, Suite 201, South Miami, FL 33143 Phone: 305-661-9404    Fax: 305-661-1510

Dr. Louis T Gidel, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 7000 Sw 62nd Ave, Suite 201, South Miami, FL 33143 Phone: 305-661-8225    Fax: 305-661-1510

Dr. Rodney Gram Benjamin, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6200 Sw 73rd St, South Miami, FL 33143 Phone: 786-662-8851    Fax: 786-662-5314

News Archive

Sorrento, TNK Therapeutics to exclusively license NanoVelcro CTC assay from CytoLumina and FetoLumina

Sorrento Therapeutics, Inc. announced today that it as well as its wholly-owned subsidiary TNK Therapeutics, Inc. have entered into a binding term sheet to exclusively license the NanoVelcro Circulating Tumor Cell (CTC) profiling assay technology from CytoLumina Technologies Corp. and FetoLumina Technologies Corp., two privately-held sister biotechnology companies in Los Angeles, California.

ARIAD's petition for rehearing the Lilly NF-Kb patent lawsuit is granted by the Federal Circuit

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and its co-plaintiffs today announced that the U.S. Court of Appeals for the Federal Circuit (the "Federal Circuit") has granted their petition for rehearing en banc and has vacated its April 2009 decision in the appeal that Eli Lilly and Co. filed in 2008. All twelve judges of the Federal Circuit will now rehear and reassess the merits of Lilly's appeal.

Cardiac specialists review benefits of 'prehabilitation' before heart surgery for older, frail patients

High risk, frail heart patients might derive benefits from "prehabilitation," a strategy designed to enhance the recovery process after heart surgery by maintaining or improving the patient's overall physical and mental status before surgery, according to a group of eminent cardiac specialists writing in the Canadian Journal of Cardiology.

Bone repair using patient's stem cells comes closer

Hitherto it has been difficult to induce adult human stem cells to produce bone, e.g. in order to repair bone tissue. Researchers at the University of Twente have shown that if the enzyme PKA is previously activated in the stem cells in the lab, following implantation this results in substantial bone formation.

Efficacy of polymeric nano-micelles depends on expression level of c-Myc

The Innovation Center of NanoMedicine (Director General: Prof. Kazunori Kataoka, Location: Kawasaki in Japan, Abbreviation: iCONM) reported in ACS Nano (Impact Factor: 14.588 in 2019) together with the group of Prof. Yu Matsumoto of Otorhinolaryngology and Head and Neck Surgery (Prof. Tatsuya Yamasoba) and the group of Prof. Horacio Cabral of the Department of Bioengineering (Prof. Ryo Miyake) in the University of Tokyo that the efficacy of polymeric nano-micelles with different drug activation profile depends on the expression level of c-Myc, one of the major proto-oncogene, has been developed.

Read more Medical News

› Verified 2 days ago